Business

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech announced today that it has been honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership recognition in the Integrated Intelligent Drug Discovery industry. As Frost & Sullivan's top honor, the award recognizes outstanding achievements in driving transformative efficiencies in preclinical research and development. It highlights Viva Biotech's consistent leadership in combining artificial intelligence (AI) with laboratory-driven validation to reshape the future of d

articleViva Biotech HoldingsSeptember 29, 20254/company/viva-biotech-holdings/news/viva-biotech-receives-frost-and-sullivans-2025-apac-technology-innovation-leadership-recognition-in-the-integrated-intelligent-drug-discovery-industry
Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

About this update from Viva Biotech Holdings

[{"type":"text","content":"Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem.","length":205,"tagName":"p"},{"type":"text","content":"SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Viva Biotech announced today that it has been honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership recognition in the Integrated Intelligent Drug Discovery industry. As Frost & Sullivan's top honor, the award recognizes outstanding achievements in driving transformative efficiencies in preclinical research and development. It highlights Viva Biotech's consistent leadership in combining artificial intelligence (AI) with laboratory-driven validation to reshape the future of drug discovery, strengthen client partnerships, and deliver scalable innovation in a highly competitive landscape.","length":674,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Viva Biotech)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Viva Biotech)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":143,"url":"https://media.zenfs.com/en/prnewswire.com/1bdaf7b965393aced1e132cf142d2b89"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t7dCRcB_pWclPGY7dRP0Yw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI1MjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/1bdaf7b965393aced1e132cf142d2b89","width":400,"height":143}},"href":"https://mma.prnewswire.com/media/2784195/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Each year, Frost & Sullivan presents this honor to a company that demonstrates outstanding strategy development and implementation. It celebrates forward-looking organizations that are redefining their industries through transformative innovation and growth excellence. Viva Biotech stood out in the rigorous benchmarking, excelling in both strategy effectiveness and execution.","length":382,"tagName":"p"},{"type":"text","content":""By integrating multimodal artificial intelligence with extensive wet lab validation, Viva Biotech has established one of the most versatile discovery platforms in the industry. Its ability to support diverse modalities—from small molecules and antibodies to emerging therapies such as PROTACs, molecular glues, and ...

More updates from Viva Biotech Holdings

Viva Biotechdrug discoveryFrost & SullivanLeadership recognitiontherapeutic innovationViva